Interestingly, the spleen size and the number of leukemia cells in mice treated with Ara-C plus FGF2 tended to be lower compared to mice treated with Ara-C alone (Fig. 4b), which may be reflecting the in vitro results that FGF2 lowered the supportive properties of stromal cells toward leukemia cells. Here, FGF2 is linked to leukemia.